Phenoxypropazine

Summary

Phenoxypropazine (CHEMBL1909286) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 166.22 Da · C9H14N2O

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1909286
Name	Phenoxypropazine
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	71467
Molecular formula	C9H14N2O
Molecular weight	166.22
InChIKey	QNEXFJFTGQBXBJ-UHFFFAOYSA-N

SMILES: CC(COC1=CC=CC=C1)NN

IUPAC name: 1-phenoxypropan-2-ylhydrazine

Also known as: Fenoxipropazina, Fenoxypropazine, Phenoxypropazine, phenoxypropazine, FENOXYPROPAZONE, SID144206870, PHENOXYPROPAZINE, fenoxypropazine

Parent form; salt/anhydrous children: CHEMBL4303424

Patent coverage: 218 distinct patent families (602 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

Broader ChEMBL bioactivity targets: 2 (assay-derived). Sample: Amine oxidase [flavin-containing] A, Prostaglandin G/H synthase 1.

Bioactivity

ChEMBL activities: 2 potent at pChembl ≥ 5 of 3 total. Top 30 by potency (10 = 0.1 nM, 6 = 1 µM):

Target	pChembl	Type	Value	Unit	Activity ID
PTGS1	6.43	AC50	371.3	nM	CHEMBL_ACT_25206419
PTGS1	6.4	AC50	395.3	nM	CHEMBL_ACT_25205489

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).